James A L, Finucane K E, Ryan G, Musk A W
Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia.
Thorax. 1988 Nov;43(11):916-22. doi: 10.1136/thx.43.11.916.
Thirty patients with stable chronic airflow obstruction receiving regular bronchodilator treatment were studied to determine whether the level of bronchial responsiveness, transfer factor for carbon monoxide (TLCO), or the mechanical properties of the lung predicted a bronchodilator response to oral corticosteroid treatment. Before treatment mean (SD) FEV1 was 48% (16%) of the predicted value (% pred); the geometric mean concentration of methacholine required to produce a 20% fall in FEV1 (PC20) was 0.44 (range 0.07-3.32) mg/ml; and TLCO was 59% (21%) predicted. The exponential constant (k) defining the shape of the static volume-pressure curve was 146% (66%) predicted and pulmonary conductance relative to predicted lung volume at a transpulmonary pressure of 5 cm H2O (sGL5) was 72% (37%) predicted. After prednisolone treatment (0.6 mg kg-1 day-1 for two weeks) FEV1 increased by 8% (19%) (p less than 0.05) and daily mean peak flow (PEF) by 3% (10%) (p less than 0.01) over pretreatment values. Three patients had an increase in FEV1 of more than 30%, two of whom had sputum eosinophilia (p less than 0.05). The three were among the 13 patients with a reduced sGL5. The increase in FEV1 did not correlate with initial PC20 (r = 0.16), k (r = -0.12), or TLCO (r = -0.14). Thus measurements of bronchial responsiveness, lung distensibility, and TLCO did not predict corticosteroid response in patients with stable chronic airflow obstruction. Patients with sputum eosinophilia or reduced pulmonary conductance may be more likely to respond.
对30例接受常规支气管扩张剂治疗的稳定期慢性气流阻塞患者进行了研究,以确定支气管反应性水平、一氧化碳转运因子(TLCO)或肺的力学特性是否能预测口服皮质类固醇治疗的支气管扩张反应。治疗前,FEV1平均值(标准差)为预测值的48%(16%);使FEV1下降20%所需的乙酰甲胆碱几何平均浓度(PC20)为0.44(范围0.07 - 3.32)mg/ml;TLCO为预测值的59%(21%)。定义静态容积 - 压力曲线形状的指数常数(k)为预测值的146%(66%),在跨肺压为5 cm H2O时相对于预测肺容积的肺传导率(sGL5)为预测值的72%(37%)。泼尼松龙治疗(0.6 mg·kg-1·d-1,持续两周)后,FEV1较治疗前值增加了8%(19%)(p < 0.05),每日平均呼气峰流速(PEF)增加了3%(10%)(p < 0.01)。3例患者FEV1增加超过30%,其中2例有痰嗜酸性粒细胞增多(p < 0.05)。这3例患者在13例sGL5降低的患者之中。FEV1的增加与初始PC20(r = 0.16)、k(r = -0.12)或TLCO(r = -0.14)均无相关性。因此,对于稳定期慢性气流阻塞患者,支气管反应性、肺扩张性和TLCO的测量不能预测皮质类固醇反应。有痰嗜酸性粒细胞增多或肺传导率降低的患者可能更易有反应。